<DOC>
	<DOCNO>NCT02113865</DOCNO>
	<brief_summary>The aim study establish clinical score panel base clinical , molecular genetic parameter allow u stratify obtain early detection patient increase risk develop hepatocellular carcinoma ( HCC ) .</brief_summary>
	<brief_title>Score System Prediction Risk Early Diagnosis HCC HIV/HCV Patients</brief_title>
	<detailed_description>Transversal study design like `` proof concept '' . Primary objective : The main objective try stablish descriptive panel ( first phase score system ) base conjunction sum several clinical laboratory parameter ( molecular genetic factor ) . The aim detect fast , early successful way patient present high risk develop hepatocellular carcinoma ( HCC ) future specific population : HIV HCV coinfected patient . The establishment panel allow clinician set correct treatment decrease probability liver cirrhosis HCC .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<mesh_term>Immunologic Deficiency Syndromes</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<criteria>Human immunodeficiency virus chronic infection Hepatitis C virus chronic infection No liver viral coinfections Alcohol consume Immunosuppressor immunoactive treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2014</verification_date>
</DOC>